NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,458 | -63.6% | 1,824 | -6.5% | 0.00% | – |
| Q2 2023 | $80,925 | -12.5% | 1,950 | +26.9% | 0.00% | -100.0% |
| Q1 2023 | $92,435 | -20.3% | 1,537 | -2.8% | 0.00% | 0.0% |
| Q4 2022 | $116,040 | -5.7% | 1,582 | -2.2% | 0.00% | 0.0% |
| Q3 2022 | $123,000 | +9.8% | 1,618 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $112,000 | -30.4% | 1,613 | -17.0% | 0.00% | 0.0% |
| Q1 2022 | $161,000 | +10.3% | 1,944 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $146,000 | -37.6% | 1,943 | -3.3% | 0.00% | 0.0% |
| Q3 2021 | $234,000 | -51.2% | 2,010 | -7.1% | 0.00% | -50.0% |
| Q2 2021 | $480,000 | +60.5% | 2,163 | -4.2% | 0.00% | +100.0% |
| Q1 2021 | $299,000 | -31.7% | 2,259 | -10.7% | 0.00% | -50.0% |
| Q4 2020 | $438,000 | +51.6% | 2,530 | -2.7% | 0.00% | +100.0% |
| Q3 2020 | $289,000 | +79.5% | 2,600 | -4.4% | 0.00% | 0.0% |
| Q2 2020 | $161,000 | -95.4% | 2,719 | -94.7% | 0.00% | -94.7% |
| Q1 2020 | $3,463,000 | -24.5% | 51,428 | -5.5% | 0.02% | +5.6% |
| Q4 2019 | $4,584,000 | +11.8% | 54,400 | -0.8% | 0.02% | +5.9% |
| Q3 2019 | $4,102,000 | +20.4% | 54,857 | +1.8% | 0.02% | +30.8% |
| Q2 2019 | $3,407,000 | +50.7% | 53,883 | +14.8% | 0.01% | +44.4% |
| Q1 2019 | $2,261,000 | +39.4% | 46,930 | -3.1% | 0.01% | +28.6% |
| Q4 2018 | $1,622,000 | -36.6% | 48,452 | -0.8% | 0.01% | -12.5% |
| Q3 2018 | $2,558,000 | +74.6% | 48,825 | +4.3% | 0.01% | +60.0% |
| Q2 2018 | $1,465,000 | +79.5% | 46,807 | +25.1% | 0.01% | +66.7% |
| Q1 2018 | $816,000 | +3.8% | 37,429 | -3.8% | 0.00% | 0.0% |
| Q4 2017 | $786,000 | +2.2% | 38,906 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $769,000 | +24.0% | 38,722 | +8.1% | 0.00% | +50.0% |
| Q2 2017 | $620,000 | +145.1% | 35,826 | +14.9% | 0.00% | +100.0% |
| Q1 2017 | $253,000 | +10.5% | 31,191 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $229,000 | -99.9% | 29,126 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $249,385,000 | -26.7% | 29,202 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $340,274,000 | +379.3% | 29,158 | +496.3% | 0.00% | – |
| Q1 2016 | $71,000,000 | – | 4,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |